Increasing geriatric population across the various countries is one of the prominent growth factors dynamically influencing the global market’s growth. The pace of aged people is increasing much faster. For example, as per the World Health Organization, the people aged above 60 and over has increased from 1 billion to 1.4 billion in 2020. In addition to this, 1 in 6 people will be more than 60 years old in the global by 2030. The need for diagnostic of various diseases is enhancing with rising aged population globally. This has further improved the urine chemistry analyzer which helps the patients to gain a valuable data regarding their health. This is broadening the market value globally. In addition to this, escalating urinary tract disorders among people is another prime aspect likely to improve the global revenue. For example, in the U.S., urinary tract disorder is most common infection where nearly 15 million women are suffering in a year. This has led the importance of diagnostic and the demand for efficient urine analyzer. Therefore, growing prevalence of such diseases is apparently improving the sales of the market. Similarly, increasing technological advancements in the field and increasing healthcare spending across many countries have led the global market grow with a considerable growth rate.
Apart From this, high cost of the system can be high which creates the hurdles to adopt for underdeveloped countries. This is restraining the growth of global market. Moreover, evolving technologies such as artificial intelligence, machine learning, and other technologies are generating plethora of opportunities in the market for urine chemistry analyzer.
New product launches to flourish in the market
In April 2023, the UF-1500 Fully Automated Urine Particle Analyzer, a brand-new instrument for use in particle analysis, has been released by Sysmex Europe. UF-1500 uses the same cutting-edge fluorescence flow cytometry technology as the UF-5000, maintaining the same high levels of capability and use while greatly reducing its footprint. In addition to this, in May 2022, the BS-600M, a strong yet effective chemistry analyzer from Mindray, is intended to boost the productivity, efficiency, and dependability of medium-volume laboratories. Moreover, in September 2021, a urinalysis analyzer was introduced by Beckman Coulter during the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell, according to the company, is a completely automated device that streamlines the workflow for urinalysis and reduces manual reviews to 4%.These advancements in the market are gaining a huge popularity and hence improving the revenue.
The urine chemistry analyzer market is categorized on the basis of type, end user, and region. By type, the market is bifurcated into benchtop and portable. By end user, it is divided into hospital and clinics. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type: The urine chemistry analyzer market is categorized into benchtop and portable. Benchtop urine chemistry analyzer is widely used in the hospitals and clinics to measure the level of blood, pH, glucose, and protein. To treat and diagnose various diseases, benchtop is fundamentally used. Portable urine chemistry analyzer used to treat various diseases can be easily moved from one place to another.
By end user: The urine chemistry analyzer market is divided into hospital and clinics. The large numbers of outpatients and inpatient admission which are seeking for the treatment or diagnosis of diseases like urinary tract disorders and chronic kidney diseases are visiting hospitals and clinics.
By region: North America is projected to account largest share of the global revenue in the fiscal year of 2021. This is attributed to numerous factors such as advancements in the healthcare infrastructure, increasing demand for point of care testing, and many more factors. Surge in cases of chronic kidney diseases in the region is major factors likely to augment the growth of market in this region. For example, more than 1 in 7 adult in the U.S. has affected with chronic kidney diseases according to U.S. Department of Health and Human Services. Centers for Disease Control and Prevention estimated around 37 million people in U.S. have chronic kidney diseases. This is significantly improving the demand for urine analyzers and hence fuelling the growth of market in the North America.
Competitive analysis and profiles of the major players in the urine chemistry analyzer end user, Abbott Diagnostics, Beckman Coulter, Horiba Ltd., Elitech Group, Johnson & Johnson, Mindray Medical International Ltd., Ortho-Clinical Diagnostics, Randox Laboratories Ltd., Roche Diagnostics, Siemens AG, and Thermo Fisher Scientificy are provided in this report.
Urine Chemistry Analyzer Market Report Highlights
By End User
Key Market Players
Randox Laboratories Ltd., Johnson & Johnson, Thermo Fisher Scientific, Mindray Medical International Ltd, Beckman Coulter, Roche Diagnostics, Elitech Group, Horiba Ltd, Abbott Diagnostics, Siemens AG, Ortho-Clinical Diagnostics